3-Chloro-2-Hydroxypropanesulfonic Acid Sodium Salt (CHPS-NA) CAS 126-83-0
Appearance: white powder
Assay: 98%
Packing: 25kg/bag
Sample: Available
related documents:
COA of 3-Chloro-2-Hydroxypropanesulfonic Acid Sodium Salt (CHPS-NA)
TDS of 3-Chloro-2-Hydroxypropanesulfonic Acid Sodium Salt (CHPS-NA)
Request for product documents,Appearance: white powder
Assay: 98%
Packing: 25kg/bag
Sample: Available
Comprehensive Guide to 3-Chloro-2-Hydroxypropanesulfonic Acid Sodium Salt (CHPS-Na) CAS 126-83-0
Table of Contents
- Product Overview & Specifications
- Key Applications & Industrial Uses
- Usage Guidelines & Best Practices
- Real-World Case Studies
- Request Customized Solutions
Product Overview & Specifications
| Parameter | CHPS-Na | Similar Compounds |
|---|---|---|
| CAS Number | 126-83-0 | CHAPS (CAS 75621-03-3) |
| Molecular Formula | C3H6ClNaO4S | C32H58N2O7S |
| Appearance | White crystalline powder | White powder (TES) |
| Solubility | Highly water-soluble (>500 g/L) | Moderate solubility (CHAPS: 100 g/L) |
| pH Stability | 2.0-12.0 | 3.0-10.0 (HEPES) |
| Purity Grade | ≥99% (HPLC) | ≥98% (Commercial grade) |
Key Applications & Industrial Uses
Biochemical Research Applications
- Protein buffer systems in electrophoresis
- Zwitterionic detergent for membrane protein studies
- Metal ion chelator in enzyme stabilization
Pharmaceutical Manufacturing
- Excipient in parenteral formulations
- Stabilizer for temperature-sensitive APIs
- Component of diagnostic reagent kits
Usage Guidelines & Best Practices
Recommended Working Concentrations
| Application | Concentration Range | Temperature Limits |
|---|---|---|
| Protein Purification | 10-50 mM | 4-25°C |
| Diagnostic Reagents | 5-20 mM | 2-8°C (long-term storage) |
Real-World Case Studies
Case Study 1: Biotech Research Facility
Challenge: Maintain enzyme activity during 72-hour stability testing
Solution: 25 mM CHPS-Na in Tris-HCl buffer (pH 7.4)
Result: 92% activity retention vs. 68% with traditional buffers
Case Study 2: Pharmaceutical Manufacturer
Challenge: Prevent aggregation in monoclonal antibody formulation
Solution: 15 mM CHPS-Na with sucrose excipient system
Result: Reduced particulates by 78% over 6-month stability study
Request Customized Solutions
Contact our technical team for application-specific formulations:
Email: info@vivalr.com
Phone: (86) 15866781826



评论
目前还没有评论。